Ganitumab
Ganitumab is a type of monoclonal antibody that is being studied in the treatment of certain types of cancer. It is a type of targeted therapy. Also called AMG 479.
Mechanism of Action
Ganitumab works by binding to the Insulin-like growth factor 1 receptor (IGF1R), which is found on the surface of many types of cancer cells. This binding blocks the action of the IGF1R, which is involved in cell growth and survival. By blocking the action of the IGF1R, ganitumab may slow the growth of cancer cells or cause them to die.
Clinical Trials
Ganitumab has been studied in clinical trials for the treatment of various types of cancer, including pancreatic cancer, Ewing's sarcoma, and ovarian cancer. Results from these trials have shown that ganitumab may have potential as a treatment for these and other types of cancer.
Side Effects
Like all chemotherapy drugs, ganitumab can cause side effects. These can vary from person to person and may include nausea, vomiting, diarrhea, and fatigue. It is important for patients to discuss any side effects they experience with their healthcare provider.
See Also
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
